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Background
According to recent studies cutaneous manifestations to
non-steroidal anti-inflammatory drugs (NSAID) may
affect 0.3% of general population and the prevalence of
aspirin hypersensitivity is as high as 27-35% in patients
with chronic urticaria (CU). NSAID may be the cause of
acute urticaria but in CU patients it usually exacerbates
the disease by inhibition of the cyclooxygenase, which
results in an increased synthesis and release of cysteinyl
leukotrienes. The aim of our study was to investigate the
incidence of reactions to NSAID as well as a possible rela-
tionship between NSAID hypersensitivity and the quality
of life, disease activity and the response to treatment in
CU patients.
Method
We observed 110 patients with CU of different severity.
Depending on the presence of reactions after NSAID
intake according to medical history and a drug provoca-
tion test (DPT), CU patients were divided into two sub-
groups: positive (n=25, 22.7%) and negative (n=85, 77.3%).
Results
The decline in the quality of life appeared to be more
sharp in the subgroup of NSAID-positive patients than in
NSAID-negative group (mean±SD: 55.9±10.9 vs 65.2
±9.7%; p=0.008). Most of NSAID-positive patients had
multiple NSAID hypersensitivity (n=15, 60%), a severe dis-
ease course (n=17, 68%) and a poor response to treatment
with antihistamines (n=13, 52%).
Conclusions
NSAID reactions may develop in about ¼ of CU
patients. DPT with aspirin is a “gold standard” which
allows to confirm the diagnosis of NSAID-induced
urticaria/angioedema in more than 90% of cases with a
corresponding history. In this case the use of the drug
should be avoided and the safety of an alternative drug
should be confirmed by oral challenge. Reactions to
NSAID are often observed in CU patients with the low
quality of life, severe disease course and poor response
to antihistamine treatment. In such patients, leukotriene
receptor antagonists taken alone or in addition to anti-
histamines may have some benefit.
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